Johnson & Johnson Makes significant Progress Towards 100% Renewable Electricity Goal with New Wind and Solar Power Purchase Agreements
As a leader in the healthcare industry, we at Johnson & Johnson know that human health is inextricably linked to the health of the planet — healthy people need a healthy planet. That’s why we are committed to environmental health and the responsible use of natural resources to ensure a better, healthier world.
Our current climate goals, including the ambitious goal to source 100% of our electricity needs from renewable sources by 2025, build on a 20-year legacy of climate commitments and achievements. In pursuit of this goal, we are proud to announce that we have executed three new virtual power purchase agreements (VPPAs) that will take us to the equivalent of 100% renewable electricity in Europe for Johnson & Johnson sites where we have operational control by 2023.
The news VPPAs include a mix of wind and solar projects in Spain for a total generation capacity of 104 megawatts (MW) or approximately 270,000 megawatt hours (MWh) of renewable electricity annually. This amount of clean energy is equivalent to avoiding the carbon emissions from more than 41,000 passenger cars per year, or the annual electricity consumption of more than 82,000 homes.
The VPPAs will cover more than 30 sites in the European region, providing the equivalent of 100% renewable electricity for all Johnson & Johnson property sites across its three business sectors — pharmaceuticals, medical devices, and consumer health — in France, Germany, Spain, UK, Sweden, Switzerland, Greece, and Italy. The new projects are expected to become operational in 2023, and would not have been financed and developed without Johnson & Johnson’s commitment, meaning the company is directly helping to accelerate the renewable energy transition in Europe.
Enel Green Power España wind plant Los Arcos, Malaga
 Johnson & Johnson property sites larger than 50,000m2, which are sites where the company has operational control